Biodesix, Inc.
BDSX
$15.86
$0.563.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.34% | 24.00% | -3.31% | -34.54% | 19.57% |
| Total Depreciation and Amortization | -1.42% | -2.02% | -0.28% | -0.62% | -2.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.22% | 6.27% | -28.14% | -12.21% | 16.10% |
| Change in Net Operating Assets | 162.66% | -235.50% | 393.91% | -212.31% | 117.93% |
| Cash from Operations | 108.76% | -35.19% | 23.65% | -110.01% | 61.62% |
| Capital Expenditure | -79.17% | 5.88% | 31.08% | 91.18% | -263.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.26% | 56.82% | 30.16% | -40.00% | 18.18% |
| Cash from Investing | -55.22% | 29.47% | 30.66% | 84.50% | -209.09% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -25.00% | 20.00% | 28.57% | 46.15% | 0.00% |
| Issuance of Common Stock | -55.25% | -- | -100.00% | 4,371.43% | -98.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -69.27% | -73.79% | 1.44% | -19.43% | 11.17% |
| Cash from Financing | -64.56% | -50.74% | 9,991.75% | 153.59% | -225.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.78% | -231.93% | 136.17% | -67.45% | 52.27% |